All News Hualan Biological Engineering Inc.

Equities

002007

CNE000001JN8

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
19.65 ^CNY	+0.26%		-1.70%	-11.21%

May. 16	Hualan Biological Engineering's Blood Centers Get License to Operate	MT
Apr. 25	Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hualan Biological Engineering's Blood Centers Get License to Operate	May. 16	MT
Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates	Apr. 01	MT
Hualan Biological Engineering Inc. Proposes Profit Distribution for 2023	Apr. 01	CI
Hualan Biological Engineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Hualan Biological Engineering Obtains Blood Collection License	Feb. 02	MT
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Hualan Biological Engineering's Plasma Station Gets Permit to Collect Blood	23-08-16	MT
Hualan Biological Engineering's Unit Gets Nod to Trial Antibody Injection	23-07-07	MT
Hualan Biological Engineering Inc. Announces Final Dividend on Share A for 2022, Payable on June 14, 2023	23-06-07	CI
Hualan Biological Engineering Obtains Blood Plasma Collection License	23-05-31	MT
Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug	23-05-05	MT
Hualan Biological Engineering Inc. Approves Cash Dividend for 2022	23-04-24	CI
Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Hualan Biological Engineering Inc. Proposes Final Dividend for 2022	23-03-30	CI
Hualan Biological Bacterin Registers Freeze-Dried Human Rabies Vaccine	23-02-01	MT
Hualan Biological Engineering Wins Approval to Build Apheresis Stations	22-12-28	MT
Hualan Biological to Sell Assets to Joint Stock Company for $27 Million	22-11-17	MT
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Hualan Biological Engineering Inc.

Equities

002007

CNE000001JN8

All News

Filters